社区医院中长效抗精神病药物与口服抗精神病药物治疗精神分裂症患者的再入院率
Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital.
作者信息
Espiridion Eduardo D, Lewandrowski Callum, Shahriari Shiva, Bestoyong Dorothy F
机构信息
Psychiatry, Frederick Memorial Hospital, Frederick, USA.
Osteopathy, West Virginia School of Osteopathic Medicine, Lewisburg, USA.
出版信息
Cureus. 2018 Dec 24;10(12):e3775. doi: 10.7759/cureus.3775.
Abstract
This is a pilot study comparing the 30 and 60 day relapse rates for schizophrenic patients treated with long-acting injectable antipsychotics versus traditional oral antipsychotics in a community hospital setting. This is a retrospective cohort study and medical records were reviewed to gather data involving readmission rates. We analyzed the data using relative risk (RR) for the 30 days and 60 days after patient discharge from the behavioral health unit of a community hospital.
摘要
这是一项试点研究，比较了在社区医院环境中，长效注射用抗精神病药物与传统口服抗精神病药物治疗的精神分裂症患者30天和60天的复发率。这是一项回顾性队列研究，通过查阅病历收集有关再入院率的数据。我们使用相对风险（RR）分析了社区医院行为健康科患者出院后30天和60天的数据。
相似文献
1
Readmission Rates of Patients with Schizophrenia Treated with Depot Antipsychotics versus Oral Antipsychotics in a Community Hospital.社区医院中长效抗精神病药物与口服抗精神病药物治疗精神分裂症患者的再入院率
Cureus. 2018 Dec 24;10(12):e3775. doi: 10.7759/cureus.3775.
2
Impact on length of stay and readmission rates when converting oral to long-acting injectable antipsychotics in schizophrenia or schizoaffective disorder.在精神分裂症或分裂情感性障碍患者中，将口服抗精神病药物转换为长效注射用抗精神病药物时对住院时间和再入院率的影响。
Ment Health Clin. 2016 Aug 31;6(5):254-259. doi: 10.9740/mhc.2016.09.254. eCollection 2016 Sep.
3
Relapse and rehospitalization: comparing oral and depot antipsychotics.复发与再次住院：口服与长效抗精神病药物的比较
J Clin Psychiatry. 2003;64 Suppl 16:14-7.
4
Long-acting injectable risperidone for the treatment of schizophrenia: clinical perspectives.长效注射用利培酮治疗精神分裂症：临床视角
Drugs. 2007;67(11):1541-66. doi: 10.2165/00003495-200767110-00003.
5
Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics.使用长效注射剂或口服抗精神病药物治疗的精神分裂症患者的医院再入院率
Psychiatr Serv. 2016 Nov 1;67(11):1183-1188. doi: 10.1176/appi.ps.201500455. Epub 2016 Jul 15.
6
Hospitalization rates and resource utilization of schizophrenic patients switched from oral antipsychotics to aripiprazole-depot in Germany.德国精神分裂症患者从口服抗精神病药物转换为阿立哌唑长效注射剂后的住院率及资源利用情况
Health Econ Rev. 2018 Nov 23;8(1):30. doi: 10.1186/s13561-018-0215-5.
7
Effectiveness of long-acting injectable risperidone versus oral antipsychotics in the treatment of recent-onset schizophrenia: a case-control study.长效注射利培酮与口服抗精神病药治疗近期发病精神分裂症的疗效比较：一项病例对照研究。
Int Clin Psychopharmacol. 2013 Jul;28(4):164-70. doi: 10.1097/YIC.0b013e3283611cc3.
8
Comparison of long-acting injectable antipsychotics with oral antipsychotics and hospital readmission rates in pediatric patients.长效注射用抗精神病药物与口服抗精神病药物的比较及儿科患者的再入院率
Ment Health Clin. 2024 Apr 1;14(2):92-96. doi: 10.9740/mhc.2024.04.092. eCollection 2024 Apr.
9
[Intervals between hospitalisations in schizophrenia patients under antipsychotics in depot-form versus oral second generation antipsychotics].[长效注射用抗精神病药物与口服第二代抗精神病药物治疗的精神分裂症患者住院间隔时间对比]
Psychiatr Prax. 2007 Sep;34(6):289-91. doi: 10.1055/s-2006-951858.
10
Efficacy and effectiveness of depot versus oral antipsychotics in schizophrenia: synthesizing results across different research designs.长效与口服抗精神病药治疗精神分裂症的疗效和效果：综合不同研究设计的结果。
J Clin Psychiatry. 2013 Jun;74(6):568-75. doi: 10.4088/JCP.12r08167. Epub 2013 Apr 19.
引用本文的文献
1
Independent Predictors of 30-Day Readmission to Acute Psychiatric Wards in Patients With Mental Disorders: A Systematic Review and Meta-Analysis.精神障碍患者30天内再次入住急性精神科病房的独立预测因素：一项系统评价和荟萃分析
Cureus. 2023 Jul 26;15(7):e42490. doi: 10.7759/cureus.42490. eCollection 2023 Jul.
2
Sociodemographic, clinical and pharmacological factors influencing early readmission in mental health settings.影响精神卫生机构患者早期再入院的社会人口学、临床和药理学因素。
Actas Esp Psiquiatr. 2022 Nov;50(6):248-255. Epub 2022 Nov 1.
3
Impact of schizophrenia relapse definition on the comparative effectiveness of oral versus injectable antipsychotics: A systematic review and meta-analysis of observational studies.精神分裂症复发定义对口服与注射用抗精神病药比较疗效的影响：观察性研究的系统评价和荟萃分析。
Pharmacol Res Perspect. 2022 Feb;10(1):e00915. doi: 10.1002/prp2.915.
本文引用的文献
1
Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials.长效注射用抗精神病药物与口服抗精神病药物预防精神分裂症复发的比较：一项随机试验的荟萃分析
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
2
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia.一项全国性队列研究：首发精神分裂症住院后使用口服和长效抗精神病药物。
Am J Psychiatry. 2011 Jun;168(6):603-9. doi: 10.1176/appi.ajp.2011.10081224. Epub 2011 Mar 1.
3
Hospital readmission as an accountability measure.将医院再入院作为一项问责措施。
JAMA. 2011 Feb 2;305(5):504-5. doi: 10.1001/jama.2011.72.
4
Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials.口服抗精神病药与长效注射剂用于精神分裂症的比较：一项基于随机长期试验的关键性系统评价和荟萃分析。
Schizophr Res. 2011 Apr;127(1-3):83-92. doi: 10.1016/j.schres.2010.11.020. Epub 2011 Jan 22.
5
Effectiveness of risperidone long-acting injection in first-episode schizophrenia: in naturalistic setting.利培酮长效注射剂治疗首发精神分裂症的有效性：在自然环境中。
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1231-5. doi: 10.1016/j.pnpbp.2008.03.012. Epub 2008 Mar 25.
6
Time to discontinuation of depot and oral first-generation antipsychotics in the usual care of schizophrenia.在精神分裂症常规治疗中停用长效和口服第一代抗精神病药物的时间。
Psychiatr Serv. 2008 Mar;59(3):315-7. doi: 10.1176/ps.2008.59.3.315.
7
Systematic meta-review of depot antipsychotic drugs for people with schizophrenia.长效抗精神病药物治疗精神分裂症患者的系统综述
Br J Psychiatry. 2001 Oct;179:290-9. doi: 10.1192/bjp.179.4.290.
Zotero 插件